December 01 2013
Coordinated by geneXplain, a new collaborative Russian-German project funded by the German BMBF and the Russian FASIE has been launched.
Coordinated by geneXplain, a new collaborative Russian-German project funded by the German BMBF and the Russian FASIE has been launched.
GeneXplain contributes to a new national research consortium on inhalation toxicity. The kick-off meeting is on Dec 12 in Hannover.
Alexander Kel, CSO of geneXplain, and Olga Kel-Margoulis, Director of Applied Life Science Informatics, are instructors at a GTPB training course in Oeiras, Portugal. Alexander is also co-organizing this year’s PathProt forum at this place.
Edgar Wingender, CEO of geneXplain, presents in the Sydney Computational Biologists meetup in Sydney (Kinghorn Cancer Centre, Oct 02) at the Walter and Eliza Hall Institute, Melbourne (Oct 08), and the University of Queensland, Brisbane (Institute for Molecular Bioscience, Oct 11).
GeneXplain sponsors and exhibits at the bioinformatic conference with the longest tradition world-wide, the German Conference of Bioinformatics in Göttingen (GCB 2013).
MatrixCatch, a novel tool for the identification of composite regulatory elements in genomic sequences, published.
GeneXplain exhibits its technology at the world’s largest bioinformatic conference, the ISMB/ECCB 2013 in Berlin.
Alexander Kel, CSO of geneXplain, lectures on “From systems biology to systems medicine. How modeling can help to design new drugs” at the Lobachevsky State University of Nizhni Novgorod.
GeneXplain’s CEO, Edgar Wingender, talked in the What Is Life seminar of the SciLifeLab, a collaborative center of Stockholm University, Karolinska Institute, the Royal Institute of Technology (KTH), and Uppsala University. The title of the lecture was “The regulatory code of the genome: mess or message?”
Edgar Wingender, CEO of geneXplain, delivered the COMPAS-lecture at Karolinska Institute, Stockholm, on the “Construction and analysis of gene regulatory networks”.
GeneXplain contributed to the first CASyM Stakeholder Conference on the implementation of Systems Medicine in Europe, held in Lyon, France.
Alexander Kel, CSO of geneXplain, presented at an Open Session of the SYSCOL project in Oxford, UK.
Edgar Wingender, CEO of geneXplain, lectures at the VIIth International Congress on “Biotechnology: State of the Art and Prospects of Development” in Moscow about “Construction of gene regulatory networks of cardiomyocyte differentiation”.
Alexander Kel, CSO of geneXplain, organizes a track on Gene Regulation at the ISCB Africa ASBCB Conference on Bioinformatics 2013 in Casablanca, Morocco.
Edgar Wingender, CEO of geneXplain, talks in the colloquium of the Helmholtz Centre for Infection Research (HZI).